Measuring the Mechanical Properties of Insulin: A Potential Solution to Overcoming the Challenges of Real-Time, Point-of-Care Insulin Sensing
- PMID: 40200746
- PMCID: PMC11982062
- DOI: 10.1177/19322968251331072
Measuring the Mechanical Properties of Insulin: A Potential Solution to Overcoming the Challenges of Real-Time, Point-of-Care Insulin Sensing
Abstract
It is well established real-time, point-of-care capabilities for insulin sensing would provide valuable insight to enhance diabetes management and care in the human body. However, such suitable technology has not yet been developed or commercialized. While not comprehensive, this commentary provides a concise summary of the motivation and challenges of developing real-time, point-of-care insulin sensing technology and offers some comments on current approaches. This short research analysis presents a new perspective on the problem and introduces a future potential solution via measuring the mechanical properties of insulin and discusses the challenges foreseen in the feasibility of this proposed solution.
Keywords: diabetes; insulin detection; micro-electro-mechanical-systems; point-of-care.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4. Diabetes Obes Metab. 2025. PMID: 40464081 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
LinkOut - more resources
Full Text Sources